Shanghai Huanghai Pharmaceutical Co., Ltd. (referred to as Shanghai Huanghai Pharma), a subsidiary of Baheal Pharmaceutical Co., Ltd. (referred to as Baheal Pharma), has been honored with the 2024 Excellence in Pharmaceutical Quality Award at the recent 2nd Pharmaceutical High-Quality Development Industry Conference and China Pharmaceutical Managers Annual Meeting. This award is a recognition of Shanghai Huanghai Pharma's outstanding quality management system and superior product quality.

On September 21, 2024, the "Collaborative Innovation and Health Future" Summit Forum, part of the 2024 World Chinese Doctors Annual Conference, took place in Qingdao. Hosted by the World Association of Chinese Doctors and co-organized by Baheal Pharma Group, the event marked the Association's 10th anniversary. As a highlight of the conference's opening ceremony, the "World Association of Chinese Doctors--Baheal Research Achievement Transformation Base" was officially signed and unveiled, witnessed by all attendees.

Baheal Medical (301015.SZ) was recently named on the "2024 China Emerging Pharmaceutical Innovators" list at the 41st National Pharmaceutical Industry Information Conference, hosted by the China National Pharmaceutical Industry Information Center...

On September 9, 2024, a signing ceremony for the establishment of the "Peking University Health Science Center----Baheal Pharma Atherosclerosis Collaborative Innovation Joint Laboratory" was held in Beijing. Baheal Pharma, in collaboration...

On September 1, 2024, the "Forum on Implementing the Spirit of the 20th Central Committee and Exploring New Opportunities for Qingdao's Development" took place at the Qingdao International Conference Center...